309 related articles for article (PubMed ID: 28808886)
21. Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer.
Turner PK; Hall SD; Chapman SC; Rehmel JL; Royalty JE; Guo Y; Kulanthaivel P
Drug Metab Dispos; 2020 Sep; 48(9):796-803. PubMed ID: 32581049
[TBL] [Abstract][Full Text] [Related]
22. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans.
Thu OK; Spigset O; Nilsen OG; Hellum B
Eur J Clin Pharmacol; 2016 Mar; 72(3):295-300. PubMed ID: 26613955
[TBL] [Abstract][Full Text] [Related]
23. Evaluating Potential Disease-Mediated Protein-Drug Interactions in Patients With Moderate-to-Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab.
Zhu Y; Xu Y; Zhuang Y; Piantone A; Shu C; Chen D; Zhou H; Xu Z; Sharma A
Clin Transl Sci; 2020 Nov; 13(6):1217-1226. PubMed ID: 32407591
[TBL] [Abstract][Full Text] [Related]
24. Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis.
Khalilieh S; Hussain A; Montgomery D; Levine V; Shaw PM; Bodrug I; Mekokishvili L; Bailey-Smith C; Glasgow XS; Cheng A; Martinho M; Iwamoto M
Br J Clin Pharmacol; 2018 Oct; 84(10):2292-2302. PubMed ID: 29926968
[TBL] [Abstract][Full Text] [Related]
25. Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats.
Zhang Y; Miao L; Lin L; Ren CY; Liu JX; Cui YM
Phytomedicine; 2018 Jan; 38():125-134. PubMed ID: 29425645
[TBL] [Abstract][Full Text] [Related]
26. Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.
Shelepova T; Nafziger AN; Victory J; Kashuba AD; Rowland E; Zhang Y; Sellers E; Kearns G; Leeder JS; Gaedigk A; Bertino JS
J Clin Pharmacol; 2005 Dec; 45(12):1413-21. PubMed ID: 16291717
[TBL] [Abstract][Full Text] [Related]
27. Effect of cenobamate on the single-dose pharmacokinetics of multiple cytochrome P450 probes using a cocktail approach in healthy subjects.
Greene SA; Kwak C; Kamin M; Vernillet L; Glenn KJ; Gabriel L; Kim HW
Clin Transl Sci; 2022 Apr; 15(4):899-911. PubMed ID: 34877801
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P-gp and BCRP.
Ou YC; Tang Z; Novotny W; Tawashi M; Li TK; Coleman HA; Sahasranaman S
Br J Clin Pharmacol; 2021 Jul; 87(7):2926-2936. PubMed ID: 33336408
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
[TBL] [Abstract][Full Text] [Related]
30. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach.
Kim MG; Kim Y; Jeon JY; Kim DS
Br J Clin Pharmacol; 2016 Dec; 82(6):1580-1590. PubMed ID: 27495955
[TBL] [Abstract][Full Text] [Related]
31. Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19.
Toda A; Uehara S; Inoue T; Utoh M; Kusama T; Shimizu M; Uno Y; Mogi M; Sasaki E; Yamazaki H
Xenobiotica; 2018 Jul; 48(7):720-726. PubMed ID: 28686070
[TBL] [Abstract][Full Text] [Related]
32. Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates.
Haberer LJ; McSherry I; Cargill A; McCarthy L
Eur J Clin Pharmacol; 2014 Jan; 70(1):37-45. PubMed ID: 24100471
[TBL] [Abstract][Full Text] [Related]
33. Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects.
Wang J; Zhang ZY; Lu S; Powers D; Kansra V; Wang X
Support Care Cancer; 2019 Mar; 27(3):819-827. PubMed ID: 30084103
[TBL] [Abstract][Full Text] [Related]
34. Effect of SHR0302 on the pharmacokinetics of CYP3A4, CYP2C8, CYP2C9 and CYP2C19 probe substrates in healthy volunteers: A cocktail analysis.
Fu M; Luo L; Feng S; Lin H; Lu Z; Gu F; Fan Y; Wu B; Huang J; Shen K
Br J Clin Pharmacol; 2023 Dec; 89(12):3659-3668. PubMed ID: 37464978
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.
Tachibana M; Papadopoulos KP; Strickler JH; Puzanov I; Gajee R; Wang Y; Zahir H
Br J Clin Pharmacol; 2018 Jan; 84(1):112-121. PubMed ID: 28865153
[TBL] [Abstract][Full Text] [Related]
37. Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.
Flaherty KT; Lathia C; Frye RF; Schuchter L; Redlinger M; Rosen M; O'Dwyer PJ
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1111-8. PubMed ID: 21350850
[TBL] [Abstract][Full Text] [Related]
38. A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects.
Achterbergh R; Lammers LA; van Nierop S; Klümpen HJ; Soeters MR; Mathôt RA; Romijn JA
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):715-20. PubMed ID: 27216294
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol.
Rowland A; van Dyk M; Warncken D; Mangoni AA; Sorich MJ; Rowland A
Br J Clin Pharmacol; 2018 Mar; 84(3):501-509. PubMed ID: 29178272
[TBL] [Abstract][Full Text] [Related]
40. Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.
Koyanagi T; Nakanishi Y; Murayama N; Yamaura Y; Ikeda K; Yano K; Uehara S; Utoh M; Kim S; Uno Y; Yamazaki H
Xenobiotica; 2015 Apr; 45(4):312-21. PubMed ID: 25364857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
